June 04, 2018
Results of the Extraordinary General Meeting held on June 4, 2018. Passing of all the resolutions. Read the Press Release
May 28, 2018
Biophytis receives favourable opinion from EMA for the Orphan Drug designation of Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release
May 24, 2018
Inclusion of the first patient in Phase 2b Study in Sarcopenia. Read the Press Release
May 16, 2018
Results of the 2018 Annual Meeting of Shareholders. Read the Press Release
May 15, 2018
Biophytis receives Orphan Drug Designation from the FDA for Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release
April 27, 2018
BIOPHYTIS updates on clinical development of Macuneos and presents its effects on visual function in a preclinical model of AMD at 2018 ARVO Congress. Read the Press Release
April 27, 2018
2017 Annual Financial Report made available. Read the Press Release
17 april 2018
Interview of Stanislas Veillet, CEO of Biophytis for the European Smallcap event 2018 with Didier Testot, journalist on the Web tv www.labourseetlavie.com
March 28, 2018
BIOPHYTIS : 2017 Full Year Results. Read the Press Release
March 20, 2018
Biophytis files for Orphan Drug Designation for Sarconeos in Duchenne Muscular Dystrophy (DMD). Read the Press Release